SWOG S1929

Primary Category:

Treatment Protocols

Disease Category:

Lung - Small Cell Extensive Stage

Status:

New, Open

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)

 

NCT#04334941